Printer Friendly

Browse Mechcatie, Elizabeth

1-300 out of 546 article(s) nextnext page
Title Type Date Words
FDA approves alirocumab, first PCSK9 inhibitor. Aug 1, 2015 780
FDA panel backs flibanserin for sexual disorder. Jul 1, 2015 828
Statin use linked with lower risk of new-onset IBD. Jun 15, 2015 530
FDA panel: Alogliptin cardiovascular risk acceptable. Clinical report May 1, 2015 683
FDA panel reassured by saxagliptin's CV safety data. May 1, 2015 564
FDA: avoid amiodarone with some hepatitis C antivirals. Apr 15, 2015 401
Panel backs ICS/LABA combo for asthma in adults. Apr 15, 2015 904
Vaccine panel: replace two flu strains for 2015-2016. Apr 1, 2015 632
FDA's mobile app provides drug shortage information. Apr 1, 2015 205
C. difficile burden linked to antibiotic resistance. Mar 15, 2015 638
ACIP recommends MenB vaccine for high-risk groups. Mar 15, 2015 610
No increased pancreatitis risk found with incretins. Mar 1, 2015 685
Panel: data weak on long-term opioids in chronic pain. Feb 15, 2015 898
FDA clears screening test for cardiac event risk. Jan 1, 2015 337
Frozen fecal capsules may be effective in C. difficile. Nov 1, 2014 527
Opioid Rx for chronic pain? Coprescribe naloxone. Oct 15, 2014 852
FDA's olmesartan probe shows no increased CV risk. Clinical report Jul 1, 2014 511
FDA requires lower starting dose for eszopiclone. Jun 1, 2014 358
No change to dabigatran label, recommendations. Jun 1, 2014 1083
Fruit, vegetable intake linked to future benefits in women. Apr 15, 2014 530
FDA panel backs cobas HPV test as primary screening tool. Apr 1, 2014 842
Injectable testosterone approved for hypogonadism. Apr 1, 2014 445
Vaccines panel: flu strains are same in 2014-2015. Mar 15, 2014 533
Pancytopenia warning added to boceprevir. Mar 15, 2014 191
Obesity treatment reimbursement is still challenging. Mar 15, 2014 731
FDA panel nixes OTC Primatene Mist replacement. Mar 15, 2014 446
Telaprevir label changes include switch to twice-daily dosing. Feb 15, 2014 290
Website outlines latest hepatitis C treatments. Website overview Feb 15, 2014 549
FDA panel rejects rivaroxaban again for ACS. Feb 1, 2014 546
FDA lifts prescribing restrictions on rosiglitazone. Dec 1, 2013 594
Once-daily protease inhibitor approved for hepatitis C. Dec 1, 2013 535
Guidelines also focus on lifestyle management, obesity. Dec 1, 2013 548
Hepatic failure flagged as boceprevir safety signal. Dec 1, 2013 369
Liver injury from herbal and dietary supplements on the rise. Dec 1, 2013 556
Panel: omega-3 pill needs more CV outcomes data. Nov 1, 2013 1049
FDA: acetaminophen tied to rare, serious skin reactions. Sep 1, 2013 423
Distinct microbiome discovery could aid Crohn's therapy. Sep 1, 2013 441
CDC panel recommends egg-free influenza vaccine. Jul 1, 2013 272
FDA panel: lift some rosiglitazone restrictions. Jun 15, 2013 928
Familiar respiratory culprits fueled Ala. illnesses. Brief article Jun 15, 2013 300
FDA: Antiseizure drugs unsafe in pregnant migraine patients. Jun 1, 2013 491
Exercise-induced bronchoconstriction? Start with SABAs. May 15, 2013 645
FDA advisory panel backs ICS/LABA inhaler for COPD. May 1, 2013 844
Gabapentin deemed ineffective for hot flashes. Apr 15, 2013 438
FDA warns of arrhythmia risk with azithromycin. Apr 1, 2013 376
FDA panel picks strains for next flu vaccine. Mar 15, 2013 634
CDC adds new influenza vaccines for next season. Mar 15, 2013 941
FDA wants safety data before degludec approval. Mar 1, 2013 326
CDC: address high smoking rate among mentally ill. Mar 1, 2013 478
FDA panel: move hydrocodone to stricter schedule II status. Report Feb 15, 2013 1056
FDA encouraging abuse deterrent opioid development. Feb 1, 2013 605
FDA panel backs canagliflozin for type 2 diabetes: committee votes 10-5 for approval, but some cite safety concerns and cardiovascular risks. Feb 1, 2013 1328
Study connects aspirin 'resistance' to enteric coating. Jan 1, 2013 884
FDA okays four-strain flu shot. Jan 1, 2013 206
FDA issues cardiovascular safety update for Chantix. Report Jan 1, 2013 447
FDA approves pasireotide for Cushing's disease. Jan 1, 2013 527
FDA panel backs avian flu vaccine for adults. Dec 1, 2012 444
Panel: safety data needed for hep B vaccine. Dec 1, 2012 651
Lung symptoms vary during menstrual cycle. Dec 1, 2012 569
Insulin degludec's duration sways FDA panel. Dec 1, 2012 807
Tofacitinib approved for rheumatoid arthritis. Nov 15, 2012 550
Bioequivalence problem results of generic Drug. Oct 15, 2012 462
First generic pioglitazone approved, with HF warning. Sep 1, 2012 288
Weight-loss drug approved, with stipulations. Aug 1, 2012 549
FDA approves generic forms of clopidogrel. Jun 15, 2012 619
CDC: screen most baby boomers for Hep. C. Jun 1, 2012 461
Lorcaserin passes panel's test for weight loss: from the food and drug administration's Endocrinologic and Metabolic Drugs advisory committee. May 15, 2012 544
VA workshop shores up veterans' resilience. May 1, 2012 551
FDA panel advises continued study of novel class for pain. Apr 1, 2012 426
COPD anticholinergic wins FDA panel support. Mar 1, 2012 599
Weight-loss drug endorsed with stipulations. Mar 1, 2012 1069
Survey: 20% of adults report mental illness. Feb 15, 2012 266
Cancer screening falls short of federal targets: disparities cited for Asians, Hispanics, and adults who lack health insurance. Feb 15, 2012 699
Vytorin falls short of new indication in CKD. Feb 1, 2012 607
FDA panel supports device for refractory GERD. Feb 1, 2012 554
U.S. continues to have HIV testing and treatment gaps. Jan 1, 2012 887
Mumps outbreaks reflect weakened immunity. Jan 1, 2012 244
Vytorin gets nod for cutting vascular events 23% in CKD: from a meeting of the FDA's Endocrinologic and Metabolic Drugs Advisory panel. Nov 15, 2011 897
Physician comment sought on opioid prescribing education program. Nov 15, 2011 217
FDA hearing scopes out drug shortage problem: in 2010, there were 178 products in short supply, up from 61 products in 2005. Nov 1, 2011 1397
Stroke risk elevated years after brain trauma. Sep 1, 2011 644
Variant Creutzfeldt-Jakob test may be on horizon. Sep 1, 2011 965
Dosing, safety data updated for varenicline. Aug 1, 2011 648
Simvastatin label now discourages higher dose. Jul 1, 2011 459
Rituximab appears safe for RA patients with lung disease. Jun 15, 2011 625
Measles importation leads to spike in U.S. cases. Jun 15, 2011 530
Even short-term NSAID use is risky after MI. Jun 1, 2011 580
FDA panel divided on fenofibric acid labeling changes. Jun 1, 2011 527
Antiretrovirals cut sexual transmission of HIV 96%. May 15, 2011 668
Protease inhibitors poised to improve HCV outcomes. May 15, 2011 554
Guidelines cover pituitary incidentaloma care. May 15, 2011 505
Panel okays new agent for C. difficile diarrhea. May 1, 2011 636
Dearth of drugs leaves few options for obesity: FDA decisions on weight-loss drugs have dimmed prospects for new medical therapies for obesity. Apr 1, 2011 1583
Flu vaccine: same strains next year, FDA panel advises. Mar 15, 2011 583
Test to detect norovirus outbreaks cleared by the FDA. Brief article Mar 1, 2011 265
Age, gender affect mental health diagnoses in recent vets. Feb 15, 2011 815
FDA tests show 'alarming variety' of undeclared drugs in supplements. Jan 1, 2011 253
FDA panel supports Combo Pill for weight loss. Jan 1, 2011 1037
FDA approves first treatment for pseudobulbar affect. Dec 1, 2010 491
FDA panel supports approval of biologic for active systemic lupus. Dec 1, 2010 326

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters